Script section containing code for Liveperson Chat Solution

Hoover's - A D&B Company - We Make It Easier
I'm Ready to Subscribe
Special Offers
DNBi. Leverage D&B's credit assessment tools.

BB BIOTECH AG · Schaffhausen Switzerland (Swiss: BIO)

Vordergasse 3Phone: +41-52-624-08-45
SchaffhausenFax: +41-52-624-60-29
CH-8200
SwitzerlandMap Map This Company
  • Company Profiles
  • Competitive Landscapes
  • Industry Reports

Buy Reports

For a Hoover's Free Trial, Call
(866) 444-8642
or
Chat Now

BB BIOTECH AG Rankings

TecDAX

Company Description

BB BIOTECH banks on genetics. The investment firm funds private and public biotechnology companies around the world. BB BIOTECH's portfolio includes significant stakes in about five companies including Actelion and Celgene. The company rounds out its portfolio with smaller stakes in about two dozen companies, keeping its holdings below 10%. BB BIOTECH prefers to invest in well-managed companies that are within two years of bringing a product to market. The company has some CHF 2.2 billion (approximately $2 billion) under management. Founded in 1993, BB BIOTECH was an early investor in Amgen, one of the biggest biotechnology companies in the world.

To read the full description: Subscribe Now
left-headBB BIOTECH AG Reports
right-head

No subscription, no problem.

Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.

Shop Reports
Shop Reports

Financials

Company TypePublic - Swiss: BIO Headquarters
Fiscal Year-EndDecember
Employees5
More BB BIOTECH AG Financials

Executives

11 executives listed for BB BIOTECH AG's Schaffhausen, Switzerland location.

Vice ChairmanDavid BaltimoreE-mail
DirectorClive MeanwellE-mail

More BB BIOTECH AG Executives

Sponsored Links